APRE vs GILD: Which Stock is Better?
Side-by-side comparison of Aprea Therapeutics Inc and Gilead Sciences Inc in 2026
APRE
Aprea Therapeutics Inc
—
GILD
Gilead Sciences Inc
$133.21
Key Metrics Comparison
| Metric | APRE | GILD | Winner |
|---|---|---|---|
| Market Cap | $10.40M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze APRE
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APRE or GILD a better investment?
Comparing APRE and GILD: Aprea Therapeutics Inc has a market cap of $10.40M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APRE and GILD?
APRE (Aprea Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APRE or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APRE or GILD?
Both APRE and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: APRE or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: APRE or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $10.40M for APRE.
Should I buy APRE or GILD in 2026?
Both APRE and GILD have investment merit. APRE trades at $N/A while GILD trades at $133.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APRE and GILD stock?
Key differences: Market Cap ($10.40M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy APRE or GILD in 2026?
The choice between APRE and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between APRE and GILD?
APRE (Aprea Therapeutics Inc) has a market cap of $10.40M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.